TOToru Ogata

Toru Ogata

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Toru Ogata has a total of 193 co-authors. Here are the top co-authors by number of shared publications:

  • Sakae Tanaka

    Department of Orthopaedic Surgery, Faculty of Medicine, The University of Tokyo, Tokyo, Japan

    7 shared publications
  • Motoshi Nagao

    Department of Rehabilitation for Motor Functions, National Rehabilitation Center for Persons with Disabilities, Tokorozawa, Japan

    6 shared publications
  • Kazuhito Morioka

    Brain and Spinal Injury Center, University of California, San Francisco, San Francisco, CA, 94110; USA

    5 shared publications
  • Kozo Nakamura

    National Rehabilitation Center for Persons with Disabilities

    5 shared publications
  • Sakae Tanaka

    Department of Orthopaedic Surgery, Sensory and Motor System Medicine, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan

    5 shared publications
  • Masami Akai

    Department of Rehabilitation for the Movement Functions, Research Institute, National Rehabilitation Center, Saitama, Japan

    4 shared publications

Latest Publications

  • Open Access

    Disuse plasticity limits spinal cord injury recovery

    by Kazuhito Morioka, Toshiki Tazoe, J. Russell Huie, Kentaro Hayakawa, Rentaro Okazaki, Cristian F. Guandique, Carlos A. Almeida, Jenny Haefeli, Makoto Hamanoue, Takashi Endoh, et al.


  • Open Access

    Author Correction: Interstitial-fluid shear stresses induced by vertically oscillating head motion lower blood pressure in hypertensive rats and humans

    by Shuhei Murase, Naoyoshi Sakitani, Takahiro Maekawa, Daisuke Yoshino, Kouji Takano, Ayumu Konno, Hirokazu Hirai, Taku Saito, Sakae Tanaka, Keisuke Shinohara, et al.

  • Open Access

    Effect of dual-task interaction combining postural and visual perturbations on cortical activity and postural control ability

    by Ryoki Nishimoto, Sayaka Fujiwara, Yumiko Kutoku, Toru Ogata, Masahito Mihara


  • Open Access

    Interstitial-fluid shear stresses induced by vertically oscillating head motion lower blood pressure in hypertensive rats and humans

    by Shuhei Murase, Naoyoshi Sakitani, Takahiro Maekawa, Daisuke Yoshino, Kouji Takano, Ayumu Konno, Hirokazu Hirai, Taku Saito, Sakae Tanaka, Keisuke Shinohara, et al.

    The mechanisms by which physical exercise benefits brain functions are not fully understood. Here, we show that vertically oscillating head motions mimicking mechanical accelerations experienced during fast walking, light jogging or treadmill running at a moderate velocity reduce the blood pressure of rats and human adults with hypertension. In hypertensive rats, shear stresses of less than 1 Pa resulting from interstitial-fluid flow induced by such passive head motions reduced the expression of the angiotensin II type-1 receptor in astrocytes in the rostral ventrolateral medulla, and the resulting antihypertensive effects were abrogated by hydrogel introduction that inhibited interstitial-fluid movement in the medulla. Our findings suggest that oscillatory mechanical interventions could be used to elicit antihypertensive effects.


  • 21. Early vs delayed surgery for incomplete cervical spinal cord injury with pre-existing cervical stenosis: the OSCIS randomized clinical trial

    by Hirotaka Chikuda, Yurie Koyama, Yoshitaka Matsubayashi, Toru Ogata, Hiroshi Ohtsu, Shurei Sugita, Masahiko Sumitani


  • Open Access

    Application of Passive Head Motion to Generate Defined Accelerations at the Heads of Rodents

    by Takahiro Maekawa, Naoyoshi Sakitani, Youngjae Ryu, Atsushi Takashima, Shuhei Murase, Julius Fink, Motoshi Nagao, Toru Ogata, Masahiro Shinohara, Yasuhiro Sawada

    Exercise is widely recognized as effective for various diseases and physical disorders, including those related to brain dysfunction. However, molecular mechanisms behind the beneficial effects of exercise are poorly understood. Many physical workouts, particularly those classified as aerobic exercises such as jogging and walking, produce impulsive forces at the time of foot contact with the ground. Therefore, it was speculated that mechanical impact might be implicated in how exercise contributes to organismal homeostasis. For testing this hypothesis on the brain, a custom-designed ''passive head motion'' (hereafter referred to as PHM) system was developed that can generate vertical accelerations with controlled and defined magnitudes and modes and reproduce mechanical stimulation that might be applied to the heads of rodents during treadmill running at moderate velocities, a typical intervention to test the effects of exercise in animals. By using this system, it was demonstrated that PHM recapitulates the serotonin (5-hydroxytryptamine, hereafter referred to as 5-HT) receptor subtype 2A (5-HT2A) signaling in the prefrontal cortex (PFC) neurons of mice. This work provides detailed protocols for applying PHM and measuring its resultant mechanical accelerations at rodents' heads.


  • Open Access

    Efficacy of Total Knee Arthroplasty in Elderly Patients With Locomotive Syndrome: a Prospective Longitudinal Study

    by Toru Ogata, Keiko Yamada, Hiromasa Miura, Kazunori Hino, Tatsuhiko Kutsuna, Kunihiko Watamori, Tomofumi Kinoshita, Yasuyuki Ishibashi, Yuji Yamamoto, Tomoyuki Sasaki, et al.

    Background: To preserve the ability to perform physical activities among the elderly, the concept of locomotive syndrome and its evaluation method, the locomotive syndrome risk test, have been applied in an integrated manner to capture the decline in mobility resulting from musculoskeletal disorders. During treatment, physicians can use the locomotive syndrome risk test to evaluate the impact of each therapy such as total knee arthroplasty for knee osteoarthritis, a common disorder found in locomotive syndrome. The purpose of this study was to evaluate the impact of total knee arthroplasty in the elderly with respect to locomotive syndrome.Methods: A total of 111 patients were registered at six hospitals prior to total knee arthroplasty and postoperatively followed up for 1 year. Three components of the locomotive syndrome risk test (the two-step test, stand-up test, and geriatric locomotive function scale-25) were assessed together with the EuroQol-5 Dimension scores pre- and postoperatively.Results: Post surgery, all three components of the locomotive syndrome risk test as well as the EuroQol-5 Dimension utility score showed significant improvements from the baseline (two-step test, 1.01±0.25 to 1.12±0.21; stand-up test, 2.02±1.14 to 2.38±1.20; geriatric locomotive function scale-25, 38.3±15.8 to 18.7±16.6, mean ± standard deviation). The ratio of stage 3 locomotive syndrome patients (progressed stage of decrease in mobility, restricting social engagement) reduced from 82.3% to 33.9% postoperatively. There was no significant difference in the degree of change in the three test scores between the younger (60-74 years) and older (≥75 years) age groups. Conclusions: We found that total knee arthroplasty has a major impact in preventing the progression of locomotive syndrome in patients with knee osteoarthritis. The locomotive syndrome risk test is a feasible tool for longitudinal evaluation of patients with musculoskeletal diseases of varying severity and with multiple symptoms.Trial registration: This study was registered as UMIN000023595 (10/08/2016)

  • Open Access

    Early escitalopram administration as a preemptive treatment strategy against spasticity after contusive spinal cord injury in rats

    by Youngjae Ryu, Toru Ogata, Motoshi Nagao, Yasuhiro Sawada, Ryohei Nishimura, Naoki Fujita

    In the majority of spinal cord injury (SCI) patients, spasticity develops in the subacute phase and chronically persists with muscle hypertonia. Among various pathological conditions underlying spasticity, upregulated expression of 5-HT receptors (5-HTR) on the spinal motor neurons due to 5-HT denervation is considered one of crucial factors for hyperexcitability of the spinal circuit. As a 5-HT signal modulator, selective serotonin re-uptake inhibitors (SSRIs) are ordinarily prescribed for diseases associated with 5-HT in the CNS, and are known for their ability to increase 5-HT levels as well as to desensitize 5-HTR. Here, we hypothesized that early SSRI administration as a preemptive treatment strategy would effectively prevent the onset of spasticity. We used a rat model of contusive SCI and administered escitalopram during the first 4 weeks after injury, which is the period required for spasticity development in rodent models. We performed a swimming test to quantify spastic behaviors and conducted the Hoffman reflex test as well as histological analyses for 5-HT2AR and KCC2 expressions. Four weeks of escitalopram administration suppressed spastic behaviors during the swimming test and reduced the population of spasticity-strong rats. Moreover, the treatment resulted in decreased immunoreactivity of 5-HT2AR in the spinal motor neurons. Result of the H-reflex test and membrane expression of KCC2 were not significantly altered. In summary, early escitalopram administration could prevent the onset of spastic behaviors via regulation of 5-HT system after SCI, but could not modulate exaggerated spinal reflex. Our results suggest a novel application of SSRIs for preventative treatment of spasticity.


  • Open Access

    Development of the Protocol to Deliver Graded Stimulation Intensity on Lower Limbs Using Belt-shaped Electrode Skeletal Muscle Stimulation

    by Toru Ogata, Hitoshi Sekiya, Yoshihiko Kono, Yoshimi Watanabe, Tsuyako Koyama, Hiromi Oda

    Objectives: Current advancements in neuromuscular electrical stimulation (NMES) include belt-shaped electrode skeletal muscle electrical stimulation (B-SES), which was developed to induce whole leg muscle contraction in a single session. Delivering the optimal amount of stimulation is critical in NMES; therefore, we set out to establish a method to determine the B-SES stimulation intensity needed to induce muscle contraction sufficient for clinical purposes. Methods: We used the Auto Tens Pro system (Homer Ion Laboratory), which is a B-SES device. Stimulation at 20 Hz was delivered for 5 s, followed by 2 s rest. Twenty-four patients who were hospitalized for musculoskeletal diseases were enrolled at two hospitals. Patients were randomly assigned to one of three groups of subjectively graded stimulation intensities: moderate, strong, or very strong. To achieve each target intensity, we developed a structured verbal instruction protocol that aimed to help therapists deliver the target level of stimulation. As a physiological assessment of muscle contraction, serum lactate levels were measured before and after a single 20-min B-SES session. Results: The electric current intensity required to achieve a target subjective muscle contraction gradually increase according to the subjective contraction level. The increase in serum lactate level was significantly larger in the very strong group than in the moderate group. Conclusions: B-SES stimulators have the potential to induce efficient muscle strengthening in patients with musculoskeletal diseases. The structured verbal protocol developed here could help therapists achieve the appropriate stimulation intensity for each patient.


  • Therapeutic Strategies for Oligodendrocyte-Mediated Remyelination

    by Toru Ogata

    Given recent progress in our understanding of oligodendrocyte biology, significant attention has been directed toward cell therapy for myelin repair and remyelination. This trend has been reinforced by findings about the importance of white matter lesions in a variety of central nervous system (CNS) diseases, including demyelinating diseases as well as brain or spinal cord trauma and degenerative disorders such as Alzheimer’s disease. Remyelination strategies include the implementation of myelin forming cells and the surrounding conditions and pathological disease context. Successful remyelination requires proper number of cells at the required location and subsequent maturation. Those processes involve variety of molecules, related to oligodendrocyte development or inflammation in the lesion. Understanding and manipulation of the functions of those molecules may improve the outcome of the cell therapies toward remyelination. Furthermore, the development of monitoring method for myelination is also anticipated to evaluate the effects of therapeutic interventions.